The stock market retreated from record opening highs following reports that a stimulus agreement looks to be on the back-burner again. Senate Leader McConnell said the Democrats shrugged off the latest proposal for a relief bill that would leave out liability protection and state aid.Meanwhile, the stock market continued to monitor the rise in virus cases and increase in lockdowns, weighing those...
Continue reading >>Vaccine stocks continue to explode higher. Moderna (MRNA) has now from $72 to $172, as it nears its meeting with the US FDA on Dec. 17 with regards to emergency use authorization.BioNTech (BNTX) has run from $90 to $130 a share, as it also nears emergency use authorization with the US FDA. Even Pfizer (PFE) has run from $35 to $43. We’d like to see the PFE stock closer to $50...
Continue reading >>The stock market retreated from record opening highs following reports that a stimulus agreement looks to be on the back-burner again. Senate Leader McConnell said the Democrats shrugged off the latest proposal for a relief bill that would leave out liability protection and state aid.Meanwhile, the stock market continued to monitor the rise in virus cases and increase in lockdowns, weighing those...
Continue reading >>...
Continue reading >>The stock market set another round of fresh all-time highs following news of the first coronavirus vaccine being delivered overseas and ongoing stimulus talks. GOP congressional leaders spoke with Treasury Secretary Mnuchin and White House Chief of Staff Meadows in hopes of getting a deal done before Congress leaves for the holidays.The Russell 2000 finished at its session high of 1,917 (+1.4%)....
Continue reading >>Keep an eye on Altimmune Inc. (ALT). The stock is pushing higher thanks to more positive data on its COVID candidate. The company just published positive pre-clinical data for its new single-dose, intranasal COVID-19 vaccine candidate AdCOVID, adding the candidate “stimulates three key immune components: serum neutralizing antibody, T cell responses, and mucosal immunity in the respiratory...
Continue reading >>